MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Automatic Detection of Nigrosome Degeneration in Susceptibility-Weighted MRI for Computer-Aided Diagnosis of Parkinson’s Disease Using Machine Learning

    B. Garcia-Santa Cruz, A. Husch, F. Hertel (Luxembourg, Luxembourg)

    Objective: Automatize the detection of ‘swallow-tail’ appearance in substantia nigra dopaminergic neurons using MRI for more robust tests on Parkinson’s disease (PD) diagnosis. Background: Differential…
  • MDS Virtual Congress 2020

    White matter microstructural abnormalities in tremor dominant and non-tremor dominant Parkinson’s disease

    P. Pal, S. Prasad, J. Saini (Bengaluru, India)

    Objective: To explore differences in white matter microstructural integrity in tremor dominant and non-tremor dominant Parkinson’s disease (PD) using tract based spatial statistics (TBSS). Background:…
  • MDS Virtual Congress 2020

    Microglial activation associated with a faster progression of nigrostriatal dysfunction in patients with isolated REM sleep behavior disorder

    K. Stær, A. Iranzo, M. Stokholm, K. Østergaard, M. Serradell, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus N, Denmark)

    Objective: To assess the role of early microglial activation on the progression of nigrostriatal dysfunction, measured with 18F-DOPA PET, in isolated REM sleep behavior disorder…
  • MDS Virtual Congress 2020

    Lack of depotentiation may not be a hallmark of Levodopa-induced dyskinesias

    A. Kishore, P. James, S. Krishnan, K. Divya, S. Meunier (Trivandrum, India)

    Objective: Paired associative stimumlation (PAS)-induced plasticity, a form of spike-time dependent plasticity (STDP), is deficient in PD. We tested whether (1) PAS-induced plasticity could be…
  • MDS Virtual Congress 2020

    Value of nocturnal hypokinesia screening concerning the quality of life and clinical features in Parkinson’s disease

    J. Choi, J. Lee, C. Shin, D. Yoo, J. Im, K. Woo, H. Kim, T. Ahn, J. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To assess nocturnal hypokinesia and its relationship with clinical features and quality of life (QoL) in patients with Parkinson’s disease (PD). Background: The nocturnal…
  • MDS Virtual Congress 2020

    Trajectories of pain in newly diagnosed Parkinson’s disease

    J. Naisby, R. Lawson, B. Galna, L. Alcock, D. Burn, L. Rochester, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the frequency and stability of pain over time in a cohort of patients with early Parkinson’s disease (PD). Background: Pain is a…
  • MDS Virtual Congress 2020

    Association between essential tremor, constipation, and the risk of developing Parkinson’s disease

    C. Reynolds, M. Gupta, M. Sandulescu (Danville, PA, USA)

    Objective: To evaluate the association between constipation and the risk of Parkinson’s disease (PD) in patients with a prior history of essential tremor (ET). Background:…
  • MDS Virtual Congress 2020

    Movement Disorders After Bariatric Surgeries – Case Series

    G. Fabiani, C.H Camargo, H. Teive (Curitiba, Brazil)

    Objective: Our objective is to report 6 cases series of MD after Bariatric surgeries (BS) and one case after hiatal surgery, with BS behavior. Background:…
  • MDS Virtual Congress 2020

    Attitudes of Care Partners Toward Medications for Parkinson’s Disease Psychosis

    S. Mantri, S. Albert, E. Klawson, L. Alzyoud, M. Daeschler, C. Kopil, C. Marras, L. Chahine (Toronto, ON, Canada)

    Objective: To explore attitudes regarding use of medications among care partners of individuals with Parkinson’s disease psychosis. Background: Parkinson’s disease (PD) psychosis is a highly…
  • MDS Virtual Congress 2020

    CVT-301 treatment provides consistent and clinically significant improvements in Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) over 12 weeks

    A. Ellenbogen, A. Corbin, P. Zhao, D. Kegler-Ebo, H. Roberts (Bingham Farms, MI, USA)

    Objective: A post hoc analysis of UPDRS-III sequential changes over the 12-week treatment period of a phase 3 study. Background: CVT-301 is an inhaled levodopa…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley